Kestra Medical Technologies, Ltd. (KMTS)Healthcare | Medical Instruments & Supplies | Kirkland, United States | NasdaqGS
26.97 USD
+0.06
(0.223%)
⇧
(Oct. 13, 2026, 4 p.m.
EDT)
After hours: 26.97 |
Hot Take ↕ | Oct. 10, 2026, 4:12 a.m. EDT
The immediate outlook remains neutral due to a lack of clear directional momentum, despite the stock trading near its 200-day average. While recent price action shows some volatility, the statistical forecasting models offer no reliable edge for the coming weeks, suggesting the market is currently pricing in uncertainty rather than a specific trend. From a long-term perspective, the investment case is severely compromised by deteriorating fundamentals. The company is generating significant losses, with negative operating cash flow and a return on equity that is deeply negative. Although revenue growth is impressive at nearly 60%, the market has punished the stock with a massive valuation multiple relative to sales, indicating skepticism about the path to profitability. Furthermore, the absence of any multi-year price history prevents a confirmation of sustained business quality, leaving the thesis reliant entirely on future execution that has yet to be proven by the stock's trajectory. Finally, there is no dividend component to this security. The company is burning through cash reserves to fund operations and growth, making any expectation of a current income stream impossible. |
| Model | MAE |
|---|---|
| MSTL ✓ | 0.055562 |
| AutoTheta | 0.059521 |
| AutoETS | 0.061713 |
| AutoARIMA | 0.061715 |
Forecast horizon: 45 days | Selected: MSTL
| Forecast Reliability | |
|---|---|
| Score | 42% |
| H-stat | 0.76 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.369 |
| Excess Kurtosis | -0.74 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 34.38 |
| Revenue per Share | 1.906 |
| Market Cap | 1,606,381,568 |
| Forward P/E | -13.12 |
| Profit Margins | -140.43% |
| Website | https://kestramedical.com |
| Attribute | Value |
|---|---|
| 52 Week Change | 0.1715281 |
| Address1 | 3,933 Lake Washington Blvd NE |
| Address2 | Suite 200 |
| All Time High | 30.0 |
| All Time Low | 13.25 |
| Ask | 34.03 |
| Ask Size | 2 |
| Audit Risk | 10 |
| Average Analyst Rating | 1.5 - Strong Buy |
| Average Daily Volume10 Day | 341,090 |
| Average Daily Volume3 Month | 351,435 |
| Average Volume | 351,435 |
| Average Volume10Days | 341,090 |
| Bid | 19.11 |
| Bid Size | 2 |
| Board Risk | 6 |
| Book Value | 3.751 |
| City | Kirkland |
| Compensation As Of Epoch Date | 1,798,675,200 |
| Compensation Risk | 10 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 26.97 |
| Current Ratio | 4.688 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,790,726,400 |
| Day High | 27.265 |
| Day Low | 26.45 |
| Debt To Equity | 34.38 |
| Display Name | Kestra Medical |
| Dividend Yield | 0.0 |
| Earnings Call Timestamp End | 1,789,417,800 |
| Earnings Call Timestamp Start | 1,789,417,800 |
| Earnings Timestamp | 1,789,416,000 |
| Earnings Timestamp End | 1,797,278,400 |
| Earnings Timestamp Start | 1,797,278,400 |
| Ebitda | -134,175,000 |
| Ebitda Margins | -1.25719 |
| Enterprise To Ebitda | -11.06 |
| Enterprise To Revenue | 13.904 |
| Enterprise Value | 1,483,916,672 |
| Eps Current Year | -2.45 |
| Eps Forward | -2.055 |
| Eps Trailing Twelve Months | -2.67 |
| Esg Populated | 0 |
| Exchange | NMS |
| Exchange Data Delayed By | 15 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 26.2442 |
| Fifty Day Average Change | 0.72579956 |
| Fifty Day Average Change Percent | 0.027655618 |
| Fifty Two Week Change Percent | 17.15281 |
| Fifty Two Week High | 30.0 |
| Fifty Two Week High Change | -3.0300007 |
| Fifty Two Week High Change Percent | -0.101000026 |
| Fifty Two Week Low | 17.34 |
| Fifty Two Week Low Change | 9.629999 |
| Fifty Two Week Low Change Percent | 0.5553633 |
| Fifty Two Week Range | 17.34 - 30.0 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,741,271,400,000 |
| Float Shares | 33,702,446 |
| Forward Eps | -2.055 |
| Forward P E | -13.124086 |
| Free Cashflow | -72,031,872 |
| Full Exchange Name | NasdaqGS |
| Full Time Employees | 443 |
| Fullday Change | 0.059999466 |
| Fullday Change Percent | 0.22296345 |
| Fullday Price | 26.97 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Governance Epoch Date | 1,790,812,800 |
| Gross Margins | 0.53886 |
| Gross Profits | 57,510,000 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.05249 |
| Held Percent Institutions | 1.01767 |
| Implied Shares Outstanding | 59,561,795 |
| Industry | Medical Instruments & Supplies |
| Industry Disp | Medical Instruments & Supplies |
| Industry Key | medical-instruments-supplies |
| Ipo Expected Date | 2,025-03-06 |
| Is Earnings Date Estimate | 1 |
| Language | en-US |
| Last Fiscal Year End | 1,777,507,200 |
| Long Business Summary | Kestra Medical Technologies, Ltd. operates as a wearable medical device and digital healthcare company. It focuses on transforming patient outcomes in cardiovascular disease through connected monitoring, therapeutic intervention, and data-driven clinical insights. The company also develops and commercializes Cardiac Recovery System platform, an integrated cardiac recovery ecosystem designed to support patients at elevated risk of sudden cardiac arrest (SCA) during vulnerable periods of recovery. Its platform provides ASSURE Wearable Cardioverter Defibrillator (WCD), which continuously monitors patient heart rhythms and automatically delivers defibrillation therapy when life-threatening ventricular arrhythmias are detected; digital patient engagement and clinical workflow solutions designed to improve patient adherence, support care coordination, and provide actionable clinical insights throughout the recovery process; and integrated platform generates continuous cardiac rhythm data and clinically actionable insights. Kestra Medical Technologies, Ltd. was founded in 2014 and is based in Kirkland, Washington. |
| Long Name | Kestra Medical Technologies, Ltd. |
| Market | us_market |
| Market Cap | 1,606,381,568 |
| Market State | POSTPOST |
| Max Age | 86,400 |
| Message Board Id | finmb_434093110 |
| Most Recent Quarter | 1,785,456,000 |
| Net Income To Common | -149,872,992 |
| Next Fiscal Year End | 1,809,043,200 |
| Non Diluted Market Cap | 1,519,421,390 |
| Number Of Analyst Opinions | 7 |
| Open | 27.0 |
| Operating Cashflow | -87,724,000 |
| Operating Margins | -1.2158799 |
| Overall Risk | 9 |
| Phone | 425 279 8002 |
| Post Market Change | 0.0 |
| Post Market Change Percent | 0.0 |
| Post Market Price | 26.97 |
| Post Market Time | 1,791,921,686 |
| Previous Close | 26.91 |
| Price Eps Current Year | -11.0081625 |
| Price Hint | 2 |
| Price To Book | 7.1900826 |
| Price To Sales Trailing12 Months | 15.051455 |
| Profit Margins | -1.40428 |
| Quick Ratio | 4.44 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | strong_buy |
| Recommendation Mean | 1.5 |
| Region | US |
| Regular Market Change | 0.0599995 |
| Regular Market Change Percent | 0.222963 |
| Regular Market Day High | 27.265 |
| Regular Market Day Low | 26.45 |
| Regular Market Day Range | 26.45 - 27.265 |
| Regular Market Open | 27.0 |
| Regular Market Previous Close | 26.91 |
| Regular Market Price | 26.97 |
| Regular Market Time | 1,791,921,601 |
| Regular Market Volume | 131,141 |
| Return On Assets | -0.29235 |
| Return On Equity | -0.73735 |
| Revenue Growth | 0.599 |
| Revenue Per Share | 1.906 |
| Sand P52 Week Change | 0.17502642 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Share Holder Rights Risk | 2 |
| Shares Outstanding | 59,561,795 |
| Shares Percent Shares Out | 0.055 |
| Shares Short | 3,277,779 |
| Shares Short Previous Month Date | 1,788,134,400 |
| Shares Short Prior Month | 2,972,015 |
| Short Name | Kestra Medical Technologies, Lt |
| Short Percent Of Float | 0.1168 |
| Short Ratio | 7.87 |
| Source Interval | 15 |
| State | WA |
| Symbol | KMTS |
| Target High Price | 32.0 |
| Target Low Price | 28.0 |
| Target Mean Price | 30.28571 |
| Target Median Price | 30.0 |
| Total Cash | 198,911,008 |
| Total Cash Per Share | 3.34 |
| Total Debt | 76,446,000 |
| Total Revenue | 106,726,000 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -2.67 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 23.586426 |
| Two Hundred Day Average Change | 3.3835735 |
| Two Hundred Day Average Change Percent | 0.14345427 |
| Type Disp | Equity |
| Volume | 131,141 |
| Website | https://kestramedical.com |
| Zip | 98,033 |